d Puma Biotechnology
Home About Us Pipeline News Investors Contacts Careers


News

Recent Press Releases Archives

Recent Press Releases

2022 News Releases

Aug. 5, 2022 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Read

Aug. 4, 2022 - Puma Biotechnology Reports Second Quarter 2022 Financial Results
Read

July 21, 2022 - Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results
Read

July 6, 2022 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Read

June 7, 2022 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Read

June 6, 2022 - Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Read

June 4, 2022 - Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT ‘Basket’ Trial of Neratinib at the ASCO 2022 Annual Meeting
Read

May 26, 2022 - Puma Biotechnology Announces Publication of Abstracts on Neratinib for the 2022 ASCO Annual Meeting
Read

May 11, 2022 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Read

May 5, 2022 - Puma Biotechnology Reports First Quarter 2022 Financial Results
Read

April 27, 2022 - Puma Biotechnology Announces Publication of Neratinib Abstract Titles for the 2022 ASCO Annual Meeting
Read

April 21, 2022 - Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results
Read

April 5, 2022 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Read

March 10, 2022 - Puma Biotechnology Announces $10 Million Private Placement
Read

March 7, 2022 - Puma Biotechnology to Participate in Breast Cancer Panel at Cowen’s Annual Health Care Conference
Read

March 4, 2022 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Read

March 3, 2022 - Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results
Read

February 16, 2022 - Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results
Read

February 3, 2022 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Read

January 20, 2022 - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Read

January 12, 2022 - Puma Biotechnology’s NERLYNX® Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer
Read

- Puma Biotechnology Releases Updated Corporate Presentation
Read

January 4, 2022 - Puma Biotechnology to Present at the H.C. Wainwright BioConnect Conference
Read




Corporate Fact Sheet

Puma Biotechnology, Inc.

10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax